Your browser doesn't support javascript.
loading
Changes in serum metabolomics in idiopathic pulmonary fibrosis and effect of approved antifibrotic medication.
Seeliger, Benjamin; Carleo, Alfonso; Wendel-Garcia, Pedro David; Fuge, Jan; Montes-Warboys, Ana; Schuchardt, Sven; Molina-Molina, Maria; Prasse, Antje.
Afiliação
  • Seeliger B; Department of Respiratory Medicine, Hannover Medical School and Biomedical Research in End-stage and Obstructive Lung Disease (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
  • Carleo A; Department of Respiratory Medicine, Hannover Medical School and Biomedical Research in End-stage and Obstructive Lung Disease (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
  • Wendel-Garcia PD; Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.
  • Fuge J; Department of Respiratory Medicine, Hannover Medical School and Biomedical Research in End-stage and Obstructive Lung Disease (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
  • Montes-Warboys A; ILD Multidisciplinary Unit, Hospital Universitari Bellvitge, IDIBELL, Universitat de Barcelona, Hospitalet de Llobregat, Barcelona, Spain.
  • Schuchardt S; Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
  • Molina-Molina M; ILD Multidisciplinary Unit, Hospital Universitari Bellvitge, IDIBELL, Universitat de Barcelona, Hospitalet de Llobregat, Barcelona, Spain.
  • Prasse A; Centro Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Front Pharmacol ; 13: 837680, 2022.
Article em En | MEDLINE | ID: mdl-36059968

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article